{"id":904392,"date":"2025-11-03T11:42:40","date_gmt":"2025-11-03T16:42:40","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/"},"modified":"2025-11-03T11:42:40","modified_gmt":"2025-11-03T16:42:40","slug":"syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/","title":{"rendered":"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">NEW YORK, Nov.  03, 2025  (GLOBE NEWSWIRE) &#8212; Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the Company will host an in-person investor event, along with a live webcast, on Monday, December 8, 2025, at 7:00 a.m. ET during the 67<sup>th<\/sup> American Society of Hematology (ASH) Annual Meeting. Members of the Syndax management team will be joined by multiple key opinion leaders to discuss data updates from the Company\u2019s Revuforj<sup>\u00ae<\/sup> (revumenib) and Niktimvo\u2122 (axatilimab-csfr) programs.<\/p>\n<p align=\"justify\">A live webcast of the event will be available on the Investor section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xwuQbMyGY5SF9skz1w3T37_zx80UUBfrHfZtWR8JqviP9tBL2oWNpJZ4yvFv6UH_OLtj5b5WaF7GfQjDS8MJiQ==\" rel=\"nofollow\" target=\"_blank\">www.syndax.com<\/a>, where a replay of the event will also be available for a limited time.<\/p>\n<p align=\"justify\">\n        <strong>About Syndax<\/strong>\n      <\/p>\n<p align=\"justify\">Syndax Pharmaceuticals\u00a0is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company&#8217;s pipeline include Revuforj<sup>\u00ae<\/sup>\u00a0(revumenib), an FDA-approved menin inhibitor, and Niktimvo\u2122 (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xwuQbMyGY5SF9skz1w3T3ypij7EwP0_XyagqMPuedfOBU9tIaBK9CIHDeZmpbUUamgYm-tYum29ps3NDQFcxv5GillvTnR-Dve-KaWhF9yxY2_gKqg5XPVFbsJTJcEsJ8zAdsyp7ywFhOP3f-aG4u-ZnvOuyCPTd-3JRl0mSQfOhkm3O_RSEy23szn9Ruh-chtdliVYQQdZ1R2O7hBQSMZAnZqc7d4N17QniVqE1l5aL3dzwJAoQLzAvaDAmlMk9MgOfEnE2pAP79gRBQ7ywR149Ypm0PV9I9nZPHFMwSRpL7k2l6VRaKCAm3e-EBqfyeSWZfaDTSX3aH8Ignp_d_5SHZVfeeDanoHSYIcAVA_cLzfR5RYz_dsxHWn2P3C2f6yAxH3a7ci1BJmQUKMUNRw==\" rel=\"nofollow\" target=\"_blank\">www.syndax.com<\/a>\u00a0or follow the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=wZYf2-B2umogMktfw-f7RyOogOxj7xYJSsO9rrfxSzm4is5Ddqcll7YKb2VRvbuV9SEDdv2xXY2QJutluucIBPvOEP1wy-4c983fVc4KwlwOA3bVtuCCAiPHw_poCn65DnBpJ-jnGfLnl1p3UZjOX-J-BLTNk5w6Ed1wrXq10NlN3OejA0pBcU5V1f_TUu8tb6VJhNKJ78XaoDsjCKEIJg==\" rel=\"nofollow\" target=\"_blank\">X<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tF0psq9irXrR7rjTKu66uEsM-yvOjoIsjUa1yAtEsROLLvdoRaLT2ufE94Pfg_sZoq4-A92L_slqq9l_oAIHbYnn9U5Zqyg8cPzxX8mdGiPXwFIVWwaJ5WyJ_SF_IQ7RJg2nYeTxTsDZt_suMZwnd5GSgTA0L7W7ow_elAKpVanGUdKCj6dh4nFnrD9yUwFlbSDN4myfczyWn3J5VXxtQ39gDo3f0d7uaLd9ZUxbSdeUQGGdZiJPG7uEI4afgqZPLTH48WplksMR46iee93lwB6JqKde9BslTfL4OSVnoO_YJtH4477XBc5k97x3HUV9sn6KMmXVuXGdtnxNujkjM-BZh3d6p0iy0Df-WQF_j6RNmph6i0SBidkjVibZb0g7eQ2VMF-sl_GTL8jS7siVLPLHxvvRINjiDJ9BX9oDRYc=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Syndax Contacts<\/strong>\n      <\/p>\n<p>Sharon Klahre<br \/>Syndax Pharmaceuticals, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bnsbfWITXErrgWozXuWLLrwBzdE98UfFDQrI3-tbccU4b3uWyX8RIOVkixgcWxoBOXsI30v3BvXvHwZlY0A74soa-ZcO5v_sXd9WVY4nKK4=\" rel=\"nofollow\" target=\"_blank\">sklahre@syndax.com<\/a><br \/>Tel 781.684.9827<\/p>\n<p>SNDX-G<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTg5YjU5YzItMWJlZi00NTU1LTkyMGEtMmRkNWVkMzFlYjIwLTEwMTY0MTItMjAyNS0xMS0wMy1lbg==\/tiny\/Syndax-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the Company will host an in-person investor event, along with a live webcast, on Monday, December 8, 2025, at 7:00 a.m. ET during the 67th American Society of Hematology (ASH) Annual Meeting. Members of the Syndax management team will be joined by multiple key opinion leaders to discuss data updates from the Company\u2019s Revuforj\u00ae (revumenib) and Niktimvo\u2122 (axatilimab-csfr) programs. A live webcast of the event will be available on the Investor section of the Company&#8217;s website at www.syndax.com, where a replay of the event will also be available for a limited time. About Syndax Syndax Pharmaceuticals\u00a0is a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904392","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the Company will host an in-person investor event, along with a live webcast, on Monday, December 8, 2025, at 7:00 a.m. ET during the 67th American Society of Hematology (ASH) Annual Meeting. Members of the Syndax management team will be joined by multiple key opinion leaders to discuss data updates from the Company\u2019s Revuforj\u00ae (revumenib) and Niktimvo\u2122 (axatilimab-csfr) programs. A live webcast of the event will be available on the Investor section of the Company&#8217;s website at www.syndax.com, where a replay of the event will also be available for a limited time. About Syndax Syndax Pharmaceuticals\u00a0is a &hellip; Continue reading &quot;Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T16:42:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025\",\"datePublished\":\"2025-11-03T16:42:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/\"},\"wordCount\":224,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/\",\"name\":\"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=\",\"datePublished\":\"2025-11-03T16:42:40+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/","og_locale":"en_US","og_type":"article","og_title":"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025 - Market Newsdesk","og_description":"NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that the Company will host an in-person investor event, along with a live webcast, on Monday, December 8, 2025, at 7:00 a.m. ET during the 67th American Society of Hematology (ASH) Annual Meeting. Members of the Syndax management team will be joined by multiple key opinion leaders to discuss data updates from the Company\u2019s Revuforj\u00ae (revumenib) and Niktimvo\u2122 (axatilimab-csfr) programs. A live webcast of the event will be available on the Investor section of the Company&#8217;s website at www.syndax.com, where a replay of the event will also be available for a limited time. About Syndax Syndax Pharmaceuticals\u00a0is a &hellip; Continue reading \"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T16:42:40+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025","datePublished":"2025-11-03T16:42:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/"},"wordCount":224,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/","name":"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=","datePublished":"2025-11-03T16:42:40+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzI4MSM3MjM3OTM3IzIwMDQ4Mzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syndax-to-host-ash-investor-event-in-person-and-via-webcast-on-december-8-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Syndax to Host ASH Investor Event in Person and via Webcast on December 8, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904392","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904392"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904392\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904392"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904392"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904392"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}